ARCHIVE SEARCH
      -OR-  
 
  NEWS CHANNELS
Fitness News
 > Asthma Allergy News
Diabetes News
Women's Health News
Men's Health News

  MY NEWS
Personal Archive
My Account

  ABOUT THIS NEWSFEED
About Us
Advertise With Us
Feed Your Site
Contact Us


Site Map
RSS News Feed 

  Website development & hosting
   by Cyber Software Solutions

 
Aspirin Linked to Reduced Growth of Ear Tumors
Risk of sporadic vestibular schwannoma growth reduced by half

FRIDAY, Jan. 31, 2014 (HealthDay News) -- Patients with sporadic vestibular schwannoma (sVS), which can cause hearing loss, are half as likely to have tumor growth if they take aspirin, according to research published in the February issue of Otology & Neurotology.

Cherian K. Kandathil, M.B.,B.S., from the Massachusetts Eye and Ear Infirmary in Boston, and colleagues retrospectively reviewed the cases of 347 patients with sVS who underwent serial magnetic resonance imaging scans. Of these, 81 took aspirin and 266 did not take aspirin.

The researchers found that 33 of the aspirin users and 154 of the non-aspirin users had tumor growth. The likelihood of tumor growth was significantly lower among aspirin users (odds ratio, 0.50), regardless of age and sex.

"Our results suggest a potential therapeutic role of aspirin in inhibiting sVS growth," Kandathil and colleagues conclude.

Abstract
Full Text (subscription or payment may be required)



Copyright © 2014 HealthDay. All rights reserved.


Back to Top Stories
  GOOGLE ADS